Tango Therapeutics Inc (TNGX)
Healthcare
Biotechnology
—
27.20 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Tango Therapeutics Inc (TNGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -44 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 | -31 | -27 | -38 | -24 | -33 | -37 | -42 | -37 | -31 | -30 | -44 | -142 | |
| 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 2.1 | |
| 5.1 | 4.9 | 4.9 | 6.7 | 7.5 | 7.2 | 7.5 | 7.3 | 6.6 | 6.6 | 6.0 | 11 | 30 | |
| -9.5 | -16 | -0.8 | -6.8 | -6.0 | -12 | -7.1 | -10 | -5.2 | -54 | 2.4 | -10 | -67 | |
| 0.7 | 0.0 | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.6 | 0.2 | 0.2 | 0.0 | 1.0 | |
| 33 | -57 | 34 | -11 | 13 | 33 | 52 | 31 | 17 | 47 | -136 | 9.6 | -62 | |
| 0.6 | 80 | 1.5 | 43 | 1.3 | 2.4 | 1.0 | 0.0 | 0.6 | 2.5 | 219 | 80 | 302 | |
| 8.8 | -7.5 | 7.9 | -6.1 | -9.6 | 1.6 | 16 | -11 | -19 | 19 | 54 | 45 | 99 | |
| -25 | -31 | -28 | -38 | -24 | -34 | -37 | -42 | -37 | -31 | -30 | -44 | -143 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.